NIMBLE-CRC: NeoImmunoModulation Before Leveraging Excision in Colorectal Rectal Cancer
Clinical trial NCT07677579 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07677579
- Sponsor
- Northwell Health
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-30
- Primary completion
- 2028-08-30
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.